278 related articles for article (PubMed ID: 32940411)
41. Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation.
Shao N; Yang J; Shang H
Neurosci Lett; 2015 Feb; 587():79-86. PubMed ID: 25484255
[TBL] [Abstract][Full Text] [Related]
42. Comparison of magnetic resonance imaging in subtypes of multiple system atrophy.
Lee EA; Cho HI; Kim SS; Lee WY
Parkinsonism Relat Disord; 2004 Aug; 10(6):363-8. PubMed ID: 15261878
[TBL] [Abstract][Full Text] [Related]
43. 99mTc-TRODAT-1 imaging of multiple system atrophy.
Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
[TBL] [Abstract][Full Text] [Related]
44. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping.
Juh R; Pae CU; Lee CU; Yang D; Chung Y; Suh T; Choe B
Neurosci Res; 2005 Jul; 52(3):211-9. PubMed ID: 15927722
[TBL] [Abstract][Full Text] [Related]
45. Magnetic resonance imaging abnormalities as a marker of multiple system atrophy in isolated rapid eye movement sleep behavior disorder.
Muñoz-Lopetegi A; Berenguer J; Iranzo A; Serradell M; Pujol T; Gaig C; Muñoz E; Tolosa E; Santamaría J
Sleep; 2021 Jan; 44(1):. PubMed ID: 32978947
[TBL] [Abstract][Full Text] [Related]
46. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker.
Watanabe H; Fukatsu H; Katsuno M; Sugiura M; Hamada K; Okada Y; Hirayama M; Ishigaki T; Sobue G
J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):103-9. PubMed ID: 14707317
[TBL] [Abstract][Full Text] [Related]
47. FDG PET in the differential diagnosis of parkinsonian disorders.
Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
[TBL] [Abstract][Full Text] [Related]
48. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
[TBL] [Abstract][Full Text] [Related]
49. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
50. Comparison of Cerebral Glucose Metabolism between Possible and Probable Multiple System Atrophy.
Kwon KY; Kim JS; Im KC; Lee MC; Chung SJ
J Mov Disord; 2009 May; 2(1):22-8. PubMed ID: 24868348
[TBL] [Abstract][Full Text] [Related]
51. Multiple System Atrophy: Phenotypic spectrum approach coupled with brain 18-FDG PET.
Grimaldi S; Boucekine M; Witjas T; Fluchère F; Renaud M; Azulay JP; Guedj E; Eusebio A
Parkinsonism Relat Disord; 2019 Oct; 67():3-9. PubMed ID: 31621603
[TBL] [Abstract][Full Text] [Related]
52. Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.
Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Kim JS
Clin Nucl Med; 2017 Feb; 42(2):e80-e87. PubMed ID: 27922865
[TBL] [Abstract][Full Text] [Related]
53. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
[TBL] [Abstract][Full Text] [Related]
54. Manual MRI morphometry in Parkinsonian syndromes.
Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
[TBL] [Abstract][Full Text] [Related]
55. Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease.
Xian WB; Shi XC; Luo GH; Yi C; Zhang XS; Pei Z
Front Aging Neurosci; 2021; 13():648531. PubMed ID: 33958998
[TBL] [Abstract][Full Text] [Related]
56. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
57. Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study.
Krismer F; Péran P; Beliveau V; Seppi K; Arribarat G; Pavy-Le Traon A; Meissner WG; Foubert-Samier A; Fabbri M; Schocke MM; Gordon MF; Wenning GK; Poewe W; Rascol O; Scherfler C
Mov Disord; 2024 Jan; 39(1):119-129. PubMed ID: 37933745
[TBL] [Abstract][Full Text] [Related]
58. Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
Liu X; Wang N; Chen C; Wu PY; Piao S; Geng D; Li Y
Acta Radiol; 2021 Feb; 62(2):234-242. PubMed ID: 32380911
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
Umemura A; Oeda T; Hayashi R; Tomita S; Kohsaka M; Yamamoto K; Sawada H
PLoS One; 2013; 8(4):e61066. PubMed ID: 23613784
[TBL] [Abstract][Full Text] [Related]
60. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
Mangesius S; Hussl A; Krismer F; Mahlknecht P; Reiter E; Tagwercher S; Djamshidian A; Schocke M; Esterhammer R; Wenning G; Müller C; Scherfler C; Gizewski ER; Poewe W; Seppi K
Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
